17 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... for COVID-19 - ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... Pharmacology #Table #Management
Antidepressant Medications Decision Aid
 - The choice of depression medications in primary care is difficult as
Antidepressant Medications ... mostly across agents ... #Management #PatientInfo ... PrimaryCare #Psychiatry #DecisionAid ... Antidepressants #Comparison
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... Each class of medications ... pharmacotherapy #table #comparison ... #management #medications
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
anti-parasitic agent ... SARS-CoV-2, the virus ... causing COVID-19 ... ivermectin… #COVID19 ... #Antiviral #Management
Neuropathic Pain: Pharmacotherapy Selection and Effectivity Decision Aid

Figure 2 provides a comparison icon array with natural
Figure 2 provides a comparison ... Adverse events, ... contribute to medication ... Effectiveness #Medications ... #Improvement #DecisionAid
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... major adverse CV events ... #diabetes #medications ... #table #comparison ... #management #endocrinology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Fibrillation RVR - Medications ... consider using the agent ... #RVR #Medications ... #management #treatment ... #comparison #table
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... - Second line agent ... #Chloroquine #COVID19 ... #Pharmacology #Management ... #Medications
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Siltuximab) in COVID19 ... correlate with severe COVID ... #Pharmacology #Management ... #Medications
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Common Rate Control Agents ... HRS Guidelines #Management ... IM #Cardiology #Afib ... #Common #Medications